pub 30day FRN

jbell on DSKJLSW7X2PROD with NOTICES

Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices
by provisions of Public Law 92–463, as
amended, (5 U.S.C. app. 2), which sets
forth standards for the formation and
use of Advisory Committees.
ACIM advises the Secretary of Health
and Human Services on department
activities and programs directed at
reducing infant mortality and improving
the health status of pregnant women
and infants. ACIM represents a publicprivate partnership at the highest level
to provide guidance and focus attention
on the policies and resources required
to address the reduction of infant
mortality and the improvement of the
health status of pregnant women and
infants. With a focus on life course, the
ACIM addresses disparities in maternal
health to improve maternal health
outcomes, including preventing and
reducing maternal mortality and severe
maternal morbidity. ACIM provides
advice on how best to coordinate
myriad federal, state, local, and private
programs and efforts that are designed
to deal with the health and social
problems impacting infant mortality and
maternal health, including
implementation of the Healthy Start
program and maternal and infant health
objectives from the National Health
Promotion and Disease Prevention
Objectives (i.e., Healthy People 2030).
The agenda for the September 21–22,
2021, meeting is being finalized and
may include the following topics:
Federal program updates; discussion of
recommendations by ACIM to the
Secretary; fatality review programs;
health of indigenous mothers and
infants; financing of care; and patientphysician racial concordance in health
care. Refer to the ACIM website for any
updated information concerning the
meeting.
Members of the public will have the
opportunity to provide written or oral
comments. Requests to submit a written
statement or make oral comments to the
ACIM should be sent to Vanessa Lee,
using the email address above at least
three business days prior to the meeting.
Public participants may submit written
statements in advance of the scheduled
meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the
order they are requested and may be
limited as time allows.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Vanessa Lee at the contact
information listed above at least 10
business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–18378 Filed 8–25–21; 8:45 am]
BILLING CODE 4165–15–P

VerDate Sep<11>2014

17:30 Aug 25, 2021

Jkt 253001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Dental and Craniofacial Research
Council, September 9, 2021, 10:00 a.m.
to September 9, 2021, 4:00 p.m.,
National Institutes of Health, National
Institute of Dental and Craniofacial Res.,
6701 Democracy Blvd., Bethesda, MD
20892 which was published in the
Federal Register on August 13, 2021, FR
Doc. 2021–17302, 86 FR 44736.
This meeting is being amended to
change the times of the Open and
Closed sessions. The Open session will
be from 9:00 a.m. to 2:30 p.m. and will
be videocast and can be accessed from
the NIH Videocasting and Podcasting
website (http://videocast.nih.gov/). The
Closed session will be from 2:45 p.m. to
3:30 p.m. The meeting is partially
Closed to the public.
Dated: August 23, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18401 Filed 8–25–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Electronic
Individual Development Plan (eIDP)
(National Eye Institute)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/

ADDRESSES:

PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

47651

PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Cesar E. Perez-Gonzalez,
Training Director, Office of the
Scientific Director, National Eye
Institute, NIH, Building 31, Room 6A22,
MSC 0250, Bethesda, Maryland 20892
or call non-toll-free number (301) 451–
6763 or Email your request, including
your address to: cesarp@nei.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on May 24, 2021, page 27856–
27857 (86 FR 27856) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The National Eye Institute (NEI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Electronic
Individual Development Plans, 0925–
NEW, XX/XX/XXXX, National Eye
Institute (NEI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The National Eye Institute’s
(NEI) Office of the Scientific Director
(OSD) goal is to train the next
generation of vision researchers and
ophthalmologists. Trainees who
participate in NEI research come with
different levels of education (student,
postbaccalaureate, predoctoral
including graduate and medical
students, postdoctoral fellows) and for
different amounts of time (6 months to
5 years). Training at the NEI focuses on
scientific and professional skill
development. To enhance their chances
of obtaining their ideal career,
completing an annual Individual

E:\FR\FM\26AUN1.SGM

26AUN1

47652

Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices

Development Plan (IDP) is an important
step in helping a trainee’s career and
professional development and is
standard practice in graduate and
postdoctoral education. An IDP is an
effective tool for trainees to think about
their career goals and skills needed to
achieve them during their time at the
NEI. Trainees work together with their
research mentor to organize and
summarize their research projects,
consider career goals, and set training
goals and expectations, both for the
mentee and mentor.
This information collection request is
to implement an electronic Individual
Development Plan (eIDP). The data
collected comes from a detailed

questionnaire focused on responses to
professional goals and expectations
while they are at the NEI. It is expected
that the trainees will complete the eIDP
annually and by doing so, it will help
enhance the effectiveness of their
training by setting clear goals that can
be monitored not only by the trainee
themselves but also by their mentor, the
Training Director, and their
Administrative Officer. In addition to
this eIDP, the system will also
implement an electronic exit survey.
The data collected comes from a
detailed questionnaire focused on
responses to questions focused on
trainee mentoring and professional
experiences at the NEI as well as their

plans after they depart. It is expected
that the trainees will complete at the
end of their tenure and that by doing so,
the NEI Training Program can learn
about ways to improve career
development opportunities for future
trainees as well as learn more about
trainee job choices to better advise
fellows. Additionally, we can use the
survey to help determine mentor
effectiveness and help identify problems
in mentoring at the NEI.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
213.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Average
time per
response
(in hours)

Total annual
burden hour

eIDP (Attachment 1) .........................
Exit Survey Part 1 (Attachment 2) ....
Exit Survey Part 2 (Attachment 3) ....

Individuals ........................................
Individuals ........................................
Individuals ........................................

150
150
150

1
1
1

1
5/60
20/60

150
13
50

Total ...........................................

...........................................................

150

150

........................

213

Dated: August 19, 2021.
Cesar E. Perez-Gonzalez,
Training Director, National Eye Institute,
National Institutes of Health.
[FR Doc. 2021–18393 Filed 8–25–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings

jbell on DSKJLSW7X2PROD with NOTICES

Number of
responses per
respondent

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational Cancer Research.
Date: October 12, 2021.
Time: 11:00 a.m. to 4:00 p.m.

VerDate Sep<11>2014

17:30 Aug 25, 2021

Jkt 253001

Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W240, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Hasan Siddiqui, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W240, Rockville,
Maryland 20850, 240–276–5122,
hasan.siddiqui@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–1: NCI
Clinical and Translational Cancer Research.
Date: October 28, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Rockville,
Maryland 20850, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Metastasis
Research Network (U54).
Date: October 28–29, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room

PO 00000

Frm 00039

Fmt 4703

Sfmt 4703

7W238, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W238, Rockville, Maryland 20850,
240–276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Proteogenomic Tumor Analysis.
Date: November 3, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Rockville, Maryland
20850, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R03
Omnibus and R21 Clinical and Translational
Research.
Date: November 3, 2021.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Kamal Datta, M.D.,
Scientific Review Officer, Program

E:\FR\FM\26AUN1.SGM

26AUN1